Joshua Bleharski

Chief Financial Officer, Ideaya Biosciences (United States).

Companies

Scribe Therapeutics, Inc.Board member Jul 23, 2026 to now¹
Ideaya Biosciences (United States)Chief financial officer Jun 27, 2025 to now²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARScribe Therapeutics, Inc., Board member
2
SEC EDGARIdeaya Biosciences (United States), Chief financial officer